Core Points - Elutia Inc. will release its first quarter 2025 financial results on May 8, 2025, after market close [1] - A conference call and webcast will be hosted by the management team at 5:00 p.m. Eastern Time on the same day [1] - The conference call can be accessed by U.S. investors at 877-407-8029 and international investors at 201-689-8029, with a Conference ID of 13753035 [1] Company Overview - Elutia develops and commercializes drug-eluting biomatrix products aimed at improving compatibility between medical devices and patients [2] - The company focuses on addressing the needs of a growing population requiring implantable technologies [2] - Elutia's mission is to humanize medicine, enabling patients to thrive without compromise [2]
Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025